SCHEMBL30095840

SCHEMBL30095840

Cn1ncc2c(O)nc(C3CC3)nc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 2/20 0.46
GAA P10253 1/20 0.36
CHRM3 P20309 2/20 0.36
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
HRH1 P35367 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
PDE8B O95263 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HTR2C P28335 3/20 0.33
BCDIN3D Q7Z5W3 1/20 0.33
PI4KA P42356 1/20 0.33
PI4K2B Q8TCG2 1/20 0.33
PI4K2A Q9BTU6 1/20 0.33
PI4KB Q9UBF8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29174903 1.00 PDE2A (0.46) PDE2AGAACHRM3PDE4APDE4B
SCHEMBL29174993 0.83 PDE2A (0.36) PDE2ACHRM3PDE4APDE4BPDE4C
SCHEMBL29174941 0.82 PDE10A (0.47) PDE2AGAACHRM3PDE4APDE4B
SCHEMBL30095656 0.82 PDE10A (0.47) PDE2AGAACHRM3PDE4APDE4B
SCHEMBL31391497 0.82 PDE2A (0.46) PDE2ACHRM3PDE4APDE4BPDE4C
SCHEMBL25746321 0.82 PDE2A (0.46) PDE2ACHRM3PDE4APDE4BPDE4C
SCHEMBL30748224 0.80 MAT2A (0.41) PDE4BKMT2AMEN1PDE8BSMN1; SMN2
SCHEMBL29174824 0.80 KDM4E (0.52) KMT2APDE8BRAB9AKDM4EPIK3CA
SCHEMBL29174825 0.80 MAT2A (0.41) PDE4BKMT2AMEN1PDE8BSMN1; SMN2
SCHEMBL30095689 0.80 KDM4E (0.52) KMT2APDE8BRAB9AKDM4EPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4346806-A2 IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE Biocryst Pharmaceuticals, Inc. (US) 2024-04-10 EP disclosed
CN-117529315-A Imidazole-containing ALK2 kinase inhibitors 生物水晶制药公司 2024-02-06 CN disclosed
WO-2022251188-A2 IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE BIOCRYST PHARMACEUTICALS, INC. (US) 2022-12-01 WO disclosed